X0306 4 2019-12-05 0 0001492658 Wright Medical Group N.V. WMGI 0001763512 Wallace Steven P. 1023 CHERRY ROAD MEMPHIS TN 38117 0 1 0 0 President, International Ordinary Shares, par value EUR 0.03 per share 2019-12-05 4 M 0 7634 26.81 A 21649 D Ordinary Shares, par value EUR 0.03 per share 2019-12-05 4 M 0 5412 27.86 A 27061 D Ordinary Shares, par value EUR 0.03 per share 2019-12-05 4 M 0 4176 24.49 A 31237 D Ordinary Shares, par value EUR 0.03 per share 2019-12-05 4 S 0 17222 29.6001 D 14015 D Stock Option (right to buy) 26.81 2019-12-05 4 M 0 7634 0 D 2027-02-16 Ordinary Shares 7634 3482 D Stock Option (right to buy) 27.86 2019-12-05 4 M 0 5412 0 D 2027-07-25 Ordinary Shares 5412 3875 D Stock Option (right to buy) 24.49 2019-12-05 4 M 0 4176 0 D 2028-07-24 Ordinary Shares 4176 8360 D Exercise and sale of vested stock options in connection with 280G tax planning Includes 1,290 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan, 5,232 shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 3,939 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.60 to $29.605, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4. This option vested with respect to 25% of the shares on February 16, 2018 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments. This option vested with respect to 25% of the shares on July 25, 2018 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments. This option vested with respect to 25% of the shares on July 24, 2019 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments. /s/Marija Nelson, attorney-in-fact 2019-12-06